Concepedia

Marion Ott

MO

22

Publications

2.8K

Citations

17

H-Index

1995

Active since

Affiliations

Roche (Switzerland)(Current)

Karlsruhe Institute of Technology

Institut Paoli-Calmettes

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori

National Center for Tumor Diseases

Marion Ott is an author at Roche (Switzerland) specializing in medicine, oncology, and business.

Top concepts

MedicineBusinessOncologyEconomicsPathologyImmunologyCancer ResearchRadiation OncologyHealthHematology

Publications per year

1995–2022

22

Publications

22

Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1

Marion Ott, Manfred Schmidt, Kerstin Schwarzwaelder et al. · Nature Medicine · 2006 · 1.2K citations

Gene Therapies, Autoimmune Disease, Novel Therapy +10

Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease

Stefan Stein, Marion Ott, Stephan Schultze‐Strasser et al. · Nature Medicine · 2010 · 774 citations · Full text

Hematological Malignancy, Autoimmune Disease, Granulocyte +12

Economic Games: An Introduction and Guide for Research

Isabel Thielmann, Robert Böhm, Marion Ott et al. · Collabra Psychology · 2021 · 107 citations · Full text

Evolutionary Game Theory, Behavioral Decision Making, Game Theory +22

Venetoclax and idasanutlin in relapsed/refractory AML: a nonrandomized, open-label phase 1b trial

Naval Daver, Monique Dail, Jacqueline S. Garcia et al. · Blood · 2022 · 94 citations · Full text

Mixed-phenotype Acute Leukemia, Pharmacotherapy, Translational Pharmacology +18

Humoral response to catumaxomab correlates with clinical outcome: Results of the pivotal phase II/III study in patients with malignant ascites

Marion Ott, Frederik Marmé, Gerhard Moldenhauer et al. · International Journal of Cancer · 2011 · 76 citations · Full text

Rows per page

1–5 of 22